Cargando…

Association of Treatment Intensity With Survival in Older Patients With Hodgkin Lymphoma

IMPORTANCE: Hodgkin lymphoma is an aggressive blood cancer that is highly curable in younger patients who receive multiagent chemotherapy. Worse survival in older patients may reflect less-aggressive treatment, competing risks of death, or different disease biological factors. OBJECTIVE: To examine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodday, Angie Mae, Hahn, Theresa, Kumar, Anita J., Lindenauer, Peter K., Friedberg, Jonathan W., Evens, Andrew M., Parsons, Susan K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531990/ https://www.ncbi.nlm.nih.gov/pubmed/34673965 http://dx.doi.org/10.1001/jamanetworkopen.2021.28373

Ejemplares similares

67409 Quantifying Unmeasured Confounding in Relationship between Treatment Intensity and Outcomes among Older Patients with Hodgkin Lymphoma (HL) using Surveillance, Epidemiology and End Results (SEER)-Medicare Data
por: Rodday, Angie Mae, et al.
Publicado: (2021)

4074 The Role of Immortal Time Bias When Linking Treatment to Outcomes among Older Patients with Incident Hodgkin Lymphoma (HL) using Surveillance, Epidemiology and End Results (SEER)-Medicare Data
por: Rodday, Angie Mae, et al.
Publicado: (2020)

3014 Identification of a Cohort to Study Treatment Patterns in Elderly Patients with Incident Hodgkin Lymphoma (HL) using Surveillance, Epidemiology and End Results (SEER)-Medicare Data
por: Rodday, Angie Mae, et al.
Publicado: (2019)

T083: The Effect of Heart Failure on Management and Outcomes of Older Patients with Hodgkin Lymphoma
por: Upshaw, Jenica, et al.
Publicado: (2022)

Risk factors for length of stay and charge per day differ between older and younger hospitalized patients with AML
por: Kumar, Anita J., et al.
Publicado: (2018)

Measuring global health-related quality of life in children undergoing hematopoietic stem cell transplant: a longitudinal study
por: Rodday, Angie Mae, et al.
Publicado: (2013)

Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children’s Oncology Group AHOD 1331 study
por: Parsons, Susan K., et al.
Publicado: (2023)

Clusters of pain trajectories among patients with sickle cell disease hospitalized for vaso‐occlusive crisis: A data‐driven approach
por: Rodday, Angie Mae, et al.
Publicado: (2020)

Patterns of healthcare utilization among patients with sickle cell disease hospitalized with pain crises
por: Rodday, Angie Mae, et al.
Publicado: (2020)

Health-related quality of life in Hodgkin lymphoma: a systematic review
por: Linendoll, Nadine, et al.
Publicado: (2016)

P010: Inferior Outcomes for Young Adults Treated on Advanced Stage Clinical Trials: Report from the HoLISTIC Consortium
por: Parsons, Susan K., et al.
Publicado: (2022)

Current directions in the treatment of classical Hodgkin lymphoma
por: Keller, Frank G., et al.
Publicado: (2023)

3365 Treatment Interruptions and Early Discontinuation of Hormone Therapy in Hormone Receptor-Positive Breast Cancer Patients
por: Mao, Daqin, et al.
Publicado: (2019)

4129 Understanding Treatment Preferences for Hodgkin Lymphoma (HL) among Physicians, Patients and Caregivers
por: Kumar, Anita J, et al.
Publicado: (2020)

The impact of classic Hodgkin lymphoma on informal caregivers: results from the CONNECT cross-sectional survey
por: Flora, Darcy R., et al.
Publicado: (2023)

Leveraging pediatric PROMIS item banks to assess physical functioning in children at risk for severe functional loss
por: Rodday, Angie Mae, et al.
Publicado: (2017)

Mitochondrial DNA Fragmentation and Risk of Non-Hodgkin Lymphoma
por: Hosgood, H. Dean, et al.
Publicado: (2023)

Observations of Oncologists on Treatment Selection With Interim Positron Emission Tomography–Adapted Approaches in Classic Hodgkin Lymphoma: The Real-World CONNECT Study
por: Parsons, Susan K., et al.
Publicado: (2023)

Early‐stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long‐term patient outcomes
por: Parsons, Susan K., et al.
Publicado: (2018)

Association of Single-Nucleotide Variants in the Human Leukocyte Antigen and Other Loci With Childhood Hodgkin Lymphoma
por: Chen, Cheng, et al.
Publicado: (2022)

668. The clinical effectiveness of Fidaxomicin compared to Vancomycin in the treatment of Clostridioides difficile infection in immunocompromised hosts, a single center study
por: Alsoubani, Majd, et al.
Publicado: (2023)

669. The clinical effectiveness of Fidaxomicin compared to Vancomycin in the treatment of Clostridioides difficile infection, a single center real-world experience
por: Alsoubani, Majd, et al.
Publicado: (2023)

Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin Lymphoma
por: Geurts, Yvonne M., et al.
Publicado: (2023)

Hodgkin’s Lymphoma in Older Patients: an Orphan Disease?
por: Thyss, Antoine, et al.
Publicado: (2014)

Improved survival time trends in Hodgkin's lymphoma
por: Koshy, Matthew, et al.
Publicado: (2016)

Cost-effectiveness of Intensive vs Standard Blood Pressure Control Among Older Patients With Hypertension
por: Liao, Chia-Te, et al.
Publicado: (2023)

Checkpoint inhibitor immunotherapy during pregnancy for relapsed–refractory Hodgkin lymphoma
por: Evens, Andrew M., et al.
Publicado: (2022)

P009: Improved Overall Survival with First-Line Brentuximab Vedotin plus Chemotherapy in Patients with Advanced Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHELON-1
por: Hutchings, Martin, et al.
Publicado: (2022)

The Impact of Protocol Assignment for Older Adolescents with Hodgkin Lymphoma
por: Pieters, Richard S., et al.
Publicado: (2014)

The influence of marital status on the survival of patients with Hodgkin lymphoma
por: Wang, Fangfang, et al.
Publicado: (2017)

T087: Brentuximab vedotin (Bv) Demonstrates Superior Event-Free Survival in Pediatric High-Risk Hodgkin Lymphoma
por: Castellino, Sharon M., et al.
Publicado: (2022)

Impact of provider-selected indication requirement on urine test utilization and positivity
por: Penney, Jessica A., et al.
Publicado: (2022)

2134: Integrating Epidemiology and Biostatistics teaching using the case method
por: Paulus, Jessica K., et al.
Publicado: (2018)

Clinical Trials Portfolio and Regulatory History of Idelalisib in Indolent Non-Hodgkin Lymphoma: A Systematic Review and Meta-analysis
por: Banerjee, Titas, et al.
Publicado: (2023)

Environmental pesticide exposure and non-Hodgkin lymphoma survival: a population-based study
por: Poh, Christina, et al.
Publicado: (2022)

Primary Non-Hodgkin's Lymphoma of the Scalp and Cranial Vault
por: Martin, Jovita, et al.
Publicado: (2012)

Hodgkin's lymphoma presenting as chylothorax
por: Verma, Sanjeev Kumar, et al.
Publicado: (2014)

The outcome of older adults with classic Hodgkin lymphoma in British Columbia
por: Cheng, Phoebe T. M., et al.
Publicado: (2022)

Older patients with Hodgkin Lymphoma: Walking the tightrope of efficacy and toxicity
por: Barrett, Aisling, et al.
Publicado: (2023)

Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin’s Lymphoma
por: Comber, Harry, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mubkq0vqtr3f3iaiis0mua47r5